Diabetes News

Endocrinology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Raskin P et al. - IDet and IGla were both effective and safe treatments for glycemic control in a basal-bolus regimen for type 2 diabetes. Clinically significant reductions in HbA1c were achieved in both groups, but with significantly less weight gain in the IDet group at comparable basal insulin dosage.

Related Articles

Design of a family-based lifestyle intervention for youth with type 2 diabetes: the TODAY study
International Journal of Obesity, 10/16/09    Relevance Score: 84%

Increasing BMI and waist circumference and prevalence of obesity among adults with Type 2 diabetes: the National Health and Nutrition Examination Surveys
Journal of Diabetes and its Complications, 11/17/09    Relevance Score: 83%

Debating cancer and diabetes in Vienna
Practice Nursing, 11/10/09    Relevance Score: 83%

The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation
Diabetologia - Clinical and Experimental Diabetes and Metabolism, 11/09/09    Relevance Score: 83%

A Simulation of the Comparative Long-term Effectiveness of Liraglutide and Glimepiride Monotherapies in Patients with Type 2 Diabetes Mellitus
Pharmacotherapy, 10/28/09    Relevance Score: 83%

Today in Diabetes...keeping you current

Depression and Diabetes: Factors Associated With Major Depression at Five-Year Follow-Up
Psychosomatics, 12/10/09

Obstructive Sleep Apnea as a Risk Factor for Type 2 Diabetes
American Journal of Medicine, 12/10/09

Association Between Adherence and Glycemic Control in Pediatric Type 1 Diabetes
Pediatrics, 12/10/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address